Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Interaction of BIRT 2584 XX and Amitriptyline
NCT02256878Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Aug 2004
- Primary completion
- Nov 2006
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of BIRT 2584 XX in psoriasis and multiple sclerosis (MS), sponsored by Boehringer Ingelheim. Primary endpoints: Area under the concentration-time curve of amitriptyline in plasma over the time interval from 0 extrapolated to infinity up to 15 days and AUC0-inf ratio of amitriptyline/nortriptyline up to 15 days. Started Aug 2004; status: completed.
02
Drugs
BIRT 2584 XX
03
Conditions
psoriasismultiple sclerosis (MS)
Beyond the preview
Go deeper on NCT02256878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02256878.